Non-homologous DNA end joining in anticancer therapy
E Pastwa, M Malinowski - Current cancer drug targets, 2007 - benthamdirect.com
Non-homologous DNA end joining (NHEJ) is the major pathway for the repair of double-
strand breaks (DSBs) in human cells. Proteins involved in NHEJ pathway can become …
strand breaks (DSBs) in human cells. Proteins involved in NHEJ pathway can become …
[引用][C] Non-Homologous DNA End Joining in Anticancer Therapy
E Pastwa, M Malinowski - Current Cancer Drug Targets, 2007 - ingentaconnect.com
Non-homologous DNA end joining (NHEJ) is the major pathway for the repair of double-
strand breaks (DSBs) in human cells. Proteins involved in NHEJ pathway can become …
strand breaks (DSBs) in human cells. Proteins involved in NHEJ pathway can become …
Non-homologous DNA end joining in anticancer therapy
E Pastwa, M Malinowski - Current cancer drug targets, 2007 - pubmed.ncbi.nlm.nih.gov
Non-homologous DNA end joining (NHEJ) is the major pathway for the repair of double-
strand breaks (DSBs) in human cells. Proteins involved in NHEJ pathway can become …
strand breaks (DSBs) in human cells. Proteins involved in NHEJ pathway can become …